Gilead
-
[BREAKING] COVID-19 Cure: Gilead Shares Remdesivir's Success in 'Crucial Study'
-
Pharma Giant Gilead Allegedly Tries to Monopolize the Coronavirus Cure; Retracts the Orphan Drug Status
-
FDA Approves Gilead Drug That Can Treat All Forms Of Hepatitis C Virus
-
Gilead Sciences Buys Nimbus Therapeutics' Liver Drug Program For $1.2 Billion
-
Jury Favors Merck Over Gilead In Hepatitis C Drug Patent Dispute
-
Gilead Pricing Strategy For Hepatitis C Drug Sovaldi Focused on Maximizing Profits Not Patients: Report
-
China Rejects Patent Application Of Gilead For $1,000 A Day Hepatitis C Drug Sovaldi
-
Gilead Fights For Hepa C Drug Patents: Activists Concerned About Drug Accessibility
-
FDA approves Gilead's Harvoni drug: Can we afford the $1125 once-a-day Hepatitis C pill?
-
Gilead shoves off Roche’s claim on Sovaldi hep C drug
-
Sovaldi hepatitis C drug at $84,000 per treatment course sparks healthcare concerns
-
Zydelig (idelalisib) gets FDA approval for 3 types of cancer: Another Gilead blockbuster drug?
Most Popular
